Delivery Order SPE2DB20D1100-SPE2DB25FZ20A

Award Date 11/22/24
Potential Completion Date 11/25/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.70 firm fixed price delivery order is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of May 13, 2025 and was awarded on May 12, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...
This is a $1,235.33 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The delivery order is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication, with a period of performance through August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,027.44 firm fixed-price delivery order is for the supply of FYCOMPA 8 MG Tablet 30s, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,011.33 firm fixed-price delivery order contract is for the supply of FYCOMPA 2 MG TABLET 30S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $1,014.78, is for the supply of FYCOMPA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 4, 2024 and uses a firm fixed-price pricing type. This order is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $1,432.44, and an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set-aside. The company holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,332.56 contract is for the supply of FYCOMPA 4 MG TABLET 30S, a prescription medication. The contract has a firm fixed price pricing type and a completion date of July 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 4 MG TABLET 30S. The contract has a firm fixed price of $5,693.50 and a period of performance through April 1, 2024. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FYCOMPA 10 MG TABLET 30S. The contract has a firm fixed price of $3,752.89 and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication FYCOMPA 12 MG TABLET 30S, with a firm fixed price ceiling value of $2,012.96 and a period of performance through July 7, 2025. The contract is not set-aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FZ20A
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,303.64 firm fixed-price contract is for the supply of FYCOMPA 12 MG tablets, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This delivery order supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

Generated 2/21/25, 9:52 AM